Skip to main content
OpenTrials
Completed

NCT Number: NCT02420535

An Innovative Caregiver Tool to Assess and Manage Behavioral Symptoms of Dementia

Behavioral symptoms that commonly occur with dementia are associated with increased health care utilization and can lead to challenges for the person living with dementia and their caregivers. Caregivers need knowledge and skills to monitor these behaviors, to identify what triggers them, and to learn how to use proven, practical medication-free strategies to prevent and manage the behaviors. The purpose of this study is to develop and test the WeCareAdvisor, a customized, internet-based computer tool for family caregivers that helps them to assess, manage and track behavioral symptoms and their contributing factors (e.g., pain, sleep disturbance), and that provides tailored strategies for in-home, medication-free behavior management. This study is a collaboration between researchers at the University of Michigan and Johns Hopkins University.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dementia Alzheimer Disease Behavior Behavioral Symptoms Brain Diseases Caregiver Burden Central Nervous System Diseases Mental Disorders Nervous System Diseases Neurocognitive Disorders Neurodegenerative Diseases Stress, Psychological Tauopathies

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Johns Hopkins School of Nursing, Baltimore, Maryland, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

General

  • Age 21 years or older
  • Ability to read, speak and understand English
  • Home location within 50 miles of the study site Caregivers (CG)
  • Active primary caregiver of a Person with Dementia (PwD) for at least 6 months and planning to remain the primary caregiver for the next 2 months
  • Currently living with the PwD
  • CG plans to live in the area for the duration of the study
  • Is familiar and comfortable utilizing technology (e.g. computers, tablets, the internet)

Persons with Dementia (PwD)

  • CG reports that the PwD exhibits at least one or more behavioral symptoms (any behavior at any frequency)
  • PwD receiving psychotropic medication or cognitive enhancers will not be excluded.
  • If PwD is on any of four classes of psychotropic medications (antidepressant, benzodiazepines, antipsychotic, or anti-convulsant) or an anti-dementia medication (memantine or a cholinesterase inhibitor), we will require that he/she have been on a stable dose for 60 days prior to enrollment (typical time frame in clinical trials) to minimize possible confounding effects of concomitant medications.
  • Clinical diagnosis of dementia (any type) or a score of less than 24 on the Mini-Mental State Examination (MMSE)

Exclusion criteria

General

  • Inability to read, speak or understand English
  • Home location greater than 50 miles from the study site
  • Lack of regular access to a telephone Caregivers (CG)
  • Reading literacy of less than 6th grade
  • Visual impairment to the extent of prohibiting interaction with the tool
  • Hearing impairment sufficient to prohibit telephone communication
  • Other self-identified mental or physical health issues that would distinctly interfere with the ability to reasonably test the tool or complete behavioral interventions (e.g. substance use disorder, schizophrenia, severe mobility issues)
  • Hospitalized more than 3 times in the past year
  • Participating in another study to help caregivers care for the person with dementia.

Persons with Dementia (PwD)

  • At a terminal phase of illness, unable to respond to the environment or with a life expectancy less than 6 months
  • Active suicide risk
  • Imminent placement to nursing home (within the next 60 days)
  • Hospitalized more than 3 times in the past year
  • Currently in another study testing a medication to control behavioral symptoms

Treatment and study plan

Immediately Receive Tool

Behavioral

One Month Delay

Behavioral

Primary outcomes

  1. Effects of the WeCareAdvisor Tool on Caregiver Upset

    Time frame: 4 weeks

    We will measure caregiver upset on a 5 point rating scale "not at all", "a little", "moderately", "very much" and "extremely"

  2. Effect of the WeCareAdvisor Tool on Caregiver Confidence

    Time frame: 4 weeks

    We will measure caregiver confidence on a 5 point rating scale "not at all", "a little", "moderately", "very much" and "extremely"

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • Johns Hopkins University

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Apr 20, 2015
Registry last updated
Dec 19, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.